PATHRYVA
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

PATHRYVA Trademark

Serial Number: 97197222 • Registration: 7282981

PATHRYVA is a trademark filed by Ascendis Pharma Endocrinology Division A/S on December 30, 2021. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Ascendis Pharma Endocrinology Division A/S (14 trademarks)

Hellerup 2900 , DK

Entity Type: 99

Trademark Details

Filing Date

December 30, 2021

Registration Date

January 23, 2024

Published for Opposition

November 7, 2023

Goods & Services

Pharmaceutical preparations for the treatment of hypoparathyroidism; pharmaceutical preparations for the treatment of growth disorders, pharmaceutical preparations for the treatment of endocrine disorders, pharmaceutical preparations for the treatment of bone disorders; diagnostic preparations for medical use, namely, diagnostic preparations for identifying and detecting hypoparathyroidism, endocrine disorders and bone disorders

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 23, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 23, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 7, 2023 NPUB
PUBLISHED FOR OPPOSITION
Nov 7, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 18, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 2, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 20, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 20, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 20, 2023 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jun 22, 2023 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jun 22, 2023 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 22, 2023 GNRN
NON-FINAL ACTION E-MAILED
Mar 22, 2023 GNRT
NON-FINAL ACTION WRITTEN
Mar 22, 2023 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 8, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 8, 2023 CRFA
ASSIGNED TO LIE
Mar 6, 2023 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Dec 22, 2022 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Dec 19, 2022 GNS3
LETTER OF SUSPENSION E-MAILED
Dec 19, 2022 GNSL
SUSPENSION LETTER WRITTEN
Dec 19, 2022 CNSL
ASSIGNED TO EXAMINER
Dec 7, 2022 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 30, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 30, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 30, 2022 TROA
ASSIGNED TO EXAMINER
Jul 29, 2022 DOCK
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 2, 2022 GNRN
NON-FINAL ACTION E-MAILED
Jun 2, 2022 GNRT
NON-FINAL ACTION WRITTEN
Jun 2, 2022 CNRT
ASSIGNED TO EXAMINER
May 23, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 5, 2022 NWOS
NEW APPLICATION ENTERED
Jan 3, 2022 NWAP